⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5960750 | 0.86 | — | — | |
| SCHEMBL631967 | 0.81 | — | — | |
| SCHEMBL537785 | 0.79 | — | — | |
| SCHEMBL14981496 | 0.79 | — | — | |
| SCHEMBL5960817 | 0.79 | CA1 (0.31) | — | |
| SCHEMBL6641375 | 0.78 | — | — | |
| SCHEMBL5960753 | 0.77 | CA2 (0.37) | — | |
| SCHEMBL22325672 | 0.76 | — | — | |
| SCHEMBL16987250 | 0.76 | — | — | |
| SCHEMBL5960772 | 0.76 | CA2 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2108 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745178-A1 | ULTRA-HIGH MOLECULAR WEIGHT POLYGLUTAMIC ACID AND PREPARATION METHOD THEREFOR | Imeik Technology Development Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| EP-4673424-A1 | LIQUID PHASE PEPTIDE SUPPORT SYNTHESIS OF PEPTIDES AND PEPTIDOMIMETICS | Regeneron Pharmaceuticals, Inc. (US) | 2026-01-07 | — | — | EP | claimed |
| US-20250289842-A1 | Processes for Making NAG-25, a Carbohydrate Targeting Moiety, and its Intermediates | AMGEN INC. | 2025-09-18 | — | — | US | claimed |
| US-12331072-B2 | Deprotection method and resin removal method in solid-phase reaction for peptide compound or amide compound, and method for producing peptide compound | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-06-17 | — | — | US | claimed |
| WO-2025104679-A1 | PROCESSES FOR MAKING INTERMEDIATES FOR ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2025-05-22 | — | — | WO | claimed |
| WO-2025083736-A1 | NOVEL PROCESS FOR THE PREPARATION OF PIRTOBRUTINIB AND ITS INTERMEDIATES THEREOF | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2025-04-24 | — | — | WO | claimed |
| CN-115976130-B | Ruimei gem Process for synthesizing intermediate | 奥锐特药业(天津)有限公司 | 2025-03-28 | — | — | CN | claimed |
| EP-4519278-A1 | PROCESSES FOR MAKING NAG-25, A CARBOHYDRATE TARGETING MOIETY, AND ITS INTERMEDIATES | Amgen Inc. (US) | 2025-03-12 | — | — | EP | claimed |
| CN-119562958-A | Methods for preparing NAG-25 carbohydrate targeting moieties and intermediates thereof | 安进公司 | 2025-03-04 | — | — | CN | claimed |
| WO-2025041809-A1 | METHOD FOR PRODUCING DEUTERATED COMPOUND | 国立大学法人九州大学 | 2025-02-27 | — | — | WO | claimed |
| EP-0487602-B1 | 5-(1-AMINOCYCLOHEXYL)-2(1H)-PYRIDINONE AND RELATED COMPOUNDS | HOECHST ROUSSEL PHARMA (US) | 1997-07-16 | — | — | EP | claimed |
| US-5426206-A | Stereospecific synthesis of aldols | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-06-20 | — | — | US | claimed |
| US-5264575-A | Reacting 1,3-benzodiazocine-8-ol derivative with lutidine/2,6-/, triisoproylsilyltrifluoro methane, formed intermediate reacted with lithium chloride, tetrabutylammonium fluoride and isocyanate | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1993-11-23 | — | — | US | claimed |
| EP-0487602-A4 | 5-(1-AMINOCYCLOHEXYL)-2(1H)-PYRIDINONE AND RELATED COMPOUNDS | — | 1993-03-17 | — | — | EP | claimed |
| EP-0487602-A1 | 5-(1-AMINOCYCLOHEXYL)-2(1H)-PYRIDINONE AND RELATED COMPOUNDS. | HOECHST ROUSSEL PHARMA (US) | 1992-06-03 | — | — | EP | claimed |
| WO-1991002721-A1 | 5-(1-AMINOCYCLOHEXYL)-2(1H)-PYRIDINONE AND RELATED COMPOUNDS | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1991-03-07 | — | — | WO | claimed |
| EP-0335292-A2 | 2,6-Methano-1,3-benzodiazocines, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1989-10-04 | — | — | EP | claimed |
| EP-0308913-A2 | 2,6-Methanopyrrolo-3-benzazocines, a process and intermediates for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1989-03-29 | — | — | EP | claimed |
| US-4772683-A | SILYLATION, AZETIDONE THIOLESTERS | BRISTOL-MYERS COMPANY (US) | 1988-09-20 | — | — | US | claimed |
| US-4639335-A | ANHYDROPENICILLIN INTERMEDIATE | BRISTOL-MYERS COMPANY (US) | 1987-01-27 | — | — | US | claimed |